trial · primary record
TEV-53408
Vitiligo
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 66 |
| Primary completion | 2029-01-31 |
| Primary endpoint | Number of Participants With at Least One Treatment-Emergent Adverse Event |
| Registry ID | NCT06625177 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:35:13.831Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06625177
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.